4 citations
,
June 2024 in “Heliyon” This study found a causal relationship between type 1 diabetes and autoimmune disorders such as SLE, RA, and MS in Europe, but not between T1DM and SLE in East Asia, highlighting the need for preventive monitoring in affected regions.
4 citations
,
May 2008 in “Clinics in Dermatology” Skin problems can indicate different diseases inside the body.
3 citations
,
January 2021 in “Journal of Research in Medical Sciences” This review examines the interplay between metabolic syndrome and dermatologic conditions and reports no clinical results, emphasizing the need for awareness of their interconnected impacts when managing inflammatory skin diseases.
3 citations
,
October 2020 in “Arthritis Care & Research” This review discusses the advancement and validation of outcome measures for pediatric systemic lupus erythematosus to improve disease monitoring and treatment precision but reports no new clinical findings.
2 citations
,
March 2015 in “Hepatitis Monthly” This case report identified dystrophic anagen effluvium as a previously unreported dermatological side effect of PEG-INF-α-2a/RBV combination therapy in a patient with chronic hepatitis C infection.
1 citations
,
January 2023 in “Research Square (Research Square)” In this report, a 61-year-old woman with vitiligo showed significant improvement after tofacitinib treatment but developed lung adenocarcinoma, highlighting potential cancer risks associated with JAK inhibitors.
1 citations
,
December 2022 in “Sultan Qaboos University medical journal” In this study, a machine learning framework incorporating the CatBoost algorithm accurately predicted Systemic Lupus Erythematosus in Omani patients, suggesting potential for early clinical intervention.
January 2026 in “Indus journal of bioscience research.” In this study, Hibiscus rosa-sinensis extract was used to formulate and evaluate herbal cosmetic creams for their antioxidant properties, stability, and effectiveness. The formulations demonstrated strong antioxidant potential, stability under various conditions, and favorable cosmetic qualities, suggesting HRS as a beneficial ingredient in skincare products.
January 2026 in “Biomedical and Biopharmaceutical Research” This study found that formulations containing pequi and buriti oils improved texture properties and significantly increased gloss in curly hair, with pequi oil also significantly enhancing tensile strength.
November 2025 in “Frontiers in Pharmacology” This review discusses the use of Traditional Chinese Medicine in burn treatment and details various herbs with potential therapeutic benefits, but reports no new clinical findings.
In this study, baricitinib treatment for severe alopecia areata was associated with complete hair regrowth after 12 months in two patients, suggesting it may be an effective alternative to traditional therapies, although safety and clinical implications need careful consideration.
December 2024 in “Ankara Universitesi Eczacilik Fakultesi Dergisi” This review highlights Nigella sativa L. (black cumin) as a plant with numerous health benefits, noting its rich nutritional profile and reported therapeutic effects such as antioxidant and anti-inflammatory activities, identified through various in vitro, in vivo, and clinical research studies.
November 2024 in “SKIN The Journal of Cutaneous Medicine” This study found extensive real-world and clinical trial exposure to baricitinib across various disease states, ages, and racial populations, contributing data to its overall profile.
January 2024 in “International Journal of Dermatology Venereology and Leprosy Sciences” This literature review indicates that tofacitinib, both orally and topically, holds promise as a safe and effective treatment for various dermatological conditions in pediatric patients, though its use requires careful consideration of its benefits and risks.
In this study conducted at an Egyptian outpatient clinic, researchers found that systemic lupus erythematosus patients who were non-adherent to medication had a higher rate of hospitalization and more clinical symptoms compared to those who adhered to their prescribed treatments.
June 2023 in “Fundamental & clinical pharmacology” This research highlights that while JAK inhibitors are effective for various inflammatory conditions, studies raise concerns about increased risks of venous and arterial thromboembolism, and cancer, particularly with tofacitinib and baricitinib, leading to European guidelines recommending caution in high-risk patients.
April 2023 in “Research Square (Research Square)” This study found that lower GPX4 mRNA levels in polymorphonuclear neutrophils of systemic lupus erythematosus patients were negatively associated with disease activity and serological markers, suggesting a diagnostic value for GPX4 mRNA.
This study found that the RADA-GHK and RADA-KGHK peptide hydrogels improved wound healing and cell growth without cytotoxicity, suggesting potential for use in skin regeneration.
March 2022 in “Journal of Pakistan Association of Dermatologists” This article reviews the mode of action, efficacy, and safety of Janus kinase inhibitors in autoimmune dermatological conditions but reports no new clinical results.
January 2022 in “International Journal of Biology Pharmacy and Allied Sciences” This article discusses autoimmune diseases, detailing their types, symptoms, and potential management strategies, without providing new clinical findings.
December 2021 in “International Journal of Biology Pharmacy and Allied Sciences” This article discusses various autoimmune diseases, including their symptoms and management, and reports no new clinical findings.
January 2016 in “Chemistry & Industry” This article discusses various aspects of hair loss but reports no new research findings.
November 2015 in “Chemical & engineering news” This study reported that topical drugs regrew hair in mice.
March 2004 in “Journal of The American Academy of Dermatology” This study found that patients with systemic lupus erythematosus and diffuse hair loss showed non-scarring alopecia without inflammation and a decrease in total hair follicles.
March 2004 in “Journal of The American Academy of Dermatology” This study found that the vehicle of hydrocortisone impacts its absorption and therapeutic effectiveness, as demonstrated by efficacy tests using UV-erythema and vasoconstriction models.
March 2004 in “Journal of The American Academy of Dermatology” This report describes a unique case of dyschromatosis universalis in a 10-year-old Haitian male, notable for the presence of a silvery sheen to his scalp hairs and eyelashes, which may represent a variation of the condition.
January 1998 in “Lasers in Surgery and Medicine” This study found that both 5-ALA and Photofrin can effectively destroy human microvascular endothelial cells in vitro and cause tissue necrosis in vivo, with Photofrin showing greater efficacy at lower concentrations or power densities.
November 2020 in “Journal of The American Academy of Dermatology” This paper discusses photobiomodulation therapy for androgenetic alopecia, focusing on the potential differences in efficacy between laser diodes and LEDs, and reports no new clinical results.
489 citations
,
November 2021 in “Signal Transduction and Targeted Therapy” This review discusses the composition, activation, and regulation of the JAK/STAT pathway and highlights its role and inhibitors in various diseases, but reports no new experimental results.
430 citations
,
July 2002 in “Journal of Endocrinology” This hypothesis paper suggests that PCOS may result from genetically determined ovarian hypersecretion of androgens, influencing hormone regulation and insulin resistance, with obesity further affecting its severity; no new clinical results are reported.